Strata Critical Medical, Inc.
Strata Critical Medical, Inc. (SRTA) Revenue
Annual & quarterly revenue history · segment & region breakdown
SRTA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsStrata Critical Medical, Inc. trailing twelve-month (TTM) revenue is $0.25B, a decrease of 20.73% year-over-year from $0.20B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.20B | -$0.05B | -20.73% |
| 2024-12-31 | $0.25B | +$0.02B | +10.44% |
| 2023-12-31 | $0.23B | +$0.08B | +54.11% |
| 2022-12-31 | $0.15B | +$0.10B | +189.20% |
| 2021-09-30 | $0.05B | +$0.03B | +115.61% |
| 2020-09-30 | $0.02B | -$0.01B | -24.88% |
| 2019-09-30 | $0.03B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Strata Critical Medical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Strata Critical Medical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Strata Critical Medical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SRTA revenue · 4 questionsSRTA's trailing twelve-month (TTM) revenue is $0.25B. That is a decrease of 20.73% year-over-year from $0.20B in FY2025.
▸ Source: FMP · Strata Critical Medical, Inc. SEC filings · GAAP · Strata Critical Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026